SecBot SecBot
EFFECT ·Filed Oct 16, 2026
CT

CTY

CITY THERAPEUTICS, INC.
NEUTRAL
Impact 5/10
Horizonimmediate Processed11d 19h ago SEC9999999995-26-003256
IPO/offering going effective
Actionable Insight • Neutral

Monitor for the pricing amendment (424B4) expected within 1-2 business days, which will disclose the IPO price, number of shares, and underwriters. The stock will begin trading shortly thereafter.

DirectionNeutral
Confidencemedium
Horizonimmediate
Latest settled — T+5d ⚠ clustered
CTY ▼ -7.28% at T+5d
NEUTRAL call -7.28% · α vs SPY -6.85% · entry $22.40 → $20.77
Next anchor: T+20d in 17d
Entry = T+0 close
Oct 16, 2026
via day close
T+1d
-4.20%
call -4.20% · α -4.62%
$21.46
settled 8d ago
T+5d
-7.28%
call -7.28% · α -6.85%
$20.77
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

City Therapeutics, Inc. received SEC effectiveness for its S-1 registration statement (File No. 333-299117) on October 15, 2026, under the 1933 Act. This enables the company to proceed with its initial public offering (IPO), with pricing expected within 1-2 days.

Key Facts

  • EFFECT notice filed October 15, 2026, for S-1 registration statement 333-299117
  • Company is a clinical-stage biopharmaceutical (SIC 2834) based in Cambridge, MA
  • Effectiveness allows the company to sell shares to the public in an IPO
  • No offering size, price range, or number of shares disclosed in the filing

Financial Impact

Undisclosed amount — no offering size or pricing details provided in the EFFECT notice

dilutioncash

Risk Factors

  • IPO pricing and demand are unknown until the 424B4 is filed
  • No financial or pipeline details in this notice — valuation is speculative
  • Market conditions at pricing may affect the offering's success

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-003256
Document: 9999999995-26-003256-index.html9999999995-26-003256
Document: 9999999995-26-003256.txt9999999995-26-003256
18 reports for CTY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CTY — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
SC 13D
NEUTRAL ★ 5/10
$20.79awaiting T+5—$20.86 (+0.34%)
Oct 26, 2026
1d ago
SC 13G
NEUTRAL ★ 4/10
$20.79awaiting T+5—$20.86 (+0.34%)
Oct 22, 2026
5d ago
SC 13G
NEUTRAL ★ 3/10
$20.77awaiting T+5—$20.86 (+0.43%)
Oct 19, 2026
8d ago
Insider Cluster
BULLISH ★ 6/10
$20.83 $20.86▲ +0.14%▲ +0.06%$20.86 (+0.14%)
Oct 19, 2026
8d ago
Press Release
NEUTRAL ★ 5/10
$20.83 $21.19▲ +1.73%▲ +1.70%$20.86 (+0.14%)
Oct 16, 2026
11d ago
424B4
NEUTRAL ★ 5/10
$21.46 $20.79▼ −3.12%▼ −2.98%$20.86 (−2.80%)
Oct 16, 2026
11d ago
EFFECT
NEUTRAL ★ 5/10
$22.40 $20.77▼ −7.28%▼ −6.85%$20.86 (−6.87%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 3/10
$22.40 $20.77▼ −7.28%▼ −6.85%$20.86 (−6.87%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 2/10
$22.40 $20.77▼ −7.28%▼ −6.85%$20.86 (−6.87%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 2/10
$22.40 $20.77▼ −7.28%▼ −6.85%$20.86 (−6.87%)
Showing 10 of 18

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 16, 2026